Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more
Market Cap & Net Worth: Shanghai Runda Med Tech Co (603108)
Shanghai Runda Med Tech Co (SHG:603108) has a market capitalization of $1.20 Billion (CN¥8.80 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #8311 globally and #1553 in its home market, demonstrating a -1.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Runda Med Tech Co's stock price CN¥14.57 by its total outstanding shares 603675824 (603.68 Million).
Shanghai Runda Med Tech Co Market Cap History: 2015 to 2026
Shanghai Runda Med Tech Co's market capitalization history from 2015 to 2026. Data shows growth from $1.49 Billion to $1.20 Billion (1.37% CAGR).
Shanghai Runda Med Tech Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Runda Med Tech Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Shanghai Runda Med Tech Co's market cap is 0.16 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
23.71x
Shanghai Runda Med Tech Co's market cap is 23.71 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.49 Billion | $1.63 Billion | $91.76 Million | 0.92x | 16.27x |
| 2016 | $1.34 Billion | $2.16 Billion | $116.43 Million | 0.62x | 11.55x |
| 2017 | $973.99 Million | $4.32 Billion | $219.19 Million | 0.23x | 4.44x |
| 2018 | $574.47 Million | $5.96 Billion | $261.95 Million | 0.10x | 2.19x |
| 2019 | $801.20 Million | $7.05 Billion | $309.51 Million | 0.11x | 2.59x |
| 2020 | $901.15 Million | $7.07 Billion | $329.98 Million | 0.13x | 2.73x |
| 2021 | $1.09 Billion | $8.86 Billion | $380.23 Million | 0.12x | 2.87x |
| 2022 | $823.57 Million | $10.49 Billion | $417.75 Million | 0.08x | 1.97x |
| 2023 | $1.67 Billion | $9.15 Billion | $273.30 Million | 0.18x | 6.13x |
| 2024 | $1.31 Billion | $8.31 Billion | $55.28 Million | 0.16x | 23.71x |
Competitor Companies of 603108 by Market Capitalization
Companies near Shanghai Runda Med Tech Co in the global market cap rankings as of March 19, 2026.
Key companies related to Shanghai Runda Med Tech Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Shanghai Runda Med Tech Co Historical Marketcap From 2015 to 2026
Between 2015 and today, Shanghai Runda Med Tech Co's market cap moved from $1.49 Billion to $ 1.20 Billion, with a yearly change of 1.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.20 Billion | -2.54% |
| 2025 | CN¥1.23 Billion | -6.15% |
| 2024 | CN¥1.31 Billion | -21.72% |
| 2023 | CN¥1.67 Billion | +103.30% |
| 2022 | CN¥823.57 Million | -24.61% |
| 2021 | CN¥1.09 Billion | +21.22% |
| 2020 | CN¥901.15 Million | +12.47% |
| 2019 | CN¥801.20 Million | +39.47% |
| 2018 | CN¥574.47 Million | -41.02% |
| 2017 | CN¥973.99 Million | -27.54% |
| 2016 | CN¥1.34 Billion | -9.95% |
| 2015 | CN¥1.49 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shanghai Runda Med Tech Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.20 Billion USD |
| MoneyControl | $1.20 Billion USD |
| MarketWatch | $1.20 Billion USD |
| marketcap.company | $1.20 Billion USD |
| Reuters | $1.20 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.